TrialThe New England journal of medicine2026

Atezolizumab plus FOLFOX for Stage III Mismatch Repair-Deficient Colon Cancer.

Frank A Sinicrope et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.